Acta Poloniae Pharmaceutica
Overview
Acta Poloniae Pharmaceutica is a reputable scientific journal that focuses on pharmaceutical research and development. It publishes original articles, reviews, and case studies related to drug discovery, formulation, delivery systems, pharmacology, and clinical pharmacy. The journal serves as a valuable resource for researchers, pharmacists, and healthcare professionals, providing insights into the latest advancements in the field of pharmaceutical sciences.
Details
Details
Abbr.
Acta Pol Pharm
Start
1937
End
Continuing
Frequency
Six no. a year
p-ISSN
0001-6837
e-ISSN
2353-5288
Country
Poland
Language
Polish
Specialties
Pharmacology
Pharmacy
Pharmacy
Metrics
Metrics
h-index / Ranks: 7077
52
SJR / Ranks: 14332
158
CiteScore / Ranks: 13177
0.90
JIF / Ranks: 7486
0.4
Recent Articles
1.
Wisniewska E, Czerw A, Makowska M, Fronczak A
Acta Pol Pharm
. 2018 Apr;
73(4):1083-1097.
PMID: 29648735
The aim of the analysis was to establish the differences between television commercials of OTC drugs broadcast in Poland and in the U.S. The study covered 100 commercials of medicinal...
2.
Kaczmarczyk-Sedlak I, Wojnar W, Zych M, Ozimina-Kaminska E, Bonka A
Acta Pol Pharm
. 2018 Apr;
73(4):1073-1081.
PMID: 29648734
Naringenin is a dietary flavanone which can be found in many products such as citrus fruits. This substance reveals multiple pharmacological activities such as antiinflammatory and antioxidative. During the menopause,...
3.
Malkowska A, Szutowski M, Dyr W, Bamburowicz-Klimkowska M
Acta Pol Pharm
. 2018 Apr;
73(4):1067-1072.
PMID: 29648733
Ethyl glucuronide (EtG) is a direct ethanol metabolite. The presence of EtG in urine can be used as a laboratory test to detect recent alcohol consumption. Several earlier studies in...
4.
Bamburowicz-Klimkowska M, Szost T, Malkowska A, Szutowski M
Acta Pol Pharm
. 2018 Apr;
73(4):1057-1066.
PMID: 29648732
This study has investigated domperidone (DOM) and quinidine (QD) interaction in the Wistar rat experimental model of repeated administration. We used nonconventional administration model consistent with occasional administration method. Difference...
5.
Rashid Z, Ranjha N, Raza H, Razzaq R, Mehmood A
Acta Pol Pharm
. 2018 Apr;
73(4):1045-1055.
PMID: 29648731
In this study, a series of pH sensitive microgels (MGs) were prepared by modified free radical suspension polymerization of 2-hydroxyethyl methacrylate (HEMA) and itaconic acid (IA), using ethylene glycol dimethacrylate...
6.
Shah A, Khan G, Ullah H, Ahmad Khan K, Ullah K, Khan S
Acta Pol Pharm
. 2018 Apr;
73(4):1037-1043.
PMID: 29648730
The present study aimed at developing the sustained release matrix tablets of enalapril maleate and evaluating the effect of polymer concentration and viscosity grade on drug release. The sustained release...
7.
Mazurek-Wadolkowska E, Winnicka K, Czyzewska U, Miltyk W
Acta Pol Pharm
. 2018 Apr;
73(4):1029-1036.
PMID: 29648729
High profitability and simplicity of direct compression, encourages pharmaceutical industry to create universal excipients to improve technology process. Prosolv® SMCC - silicified microcrystalline cellulose and Starch 1500® - pregelatinized starch,...
8.
Ullah M, Murtaza G, Hussain I
Acta Pol Pharm
. 2018 Apr;
73(4):1023-1027.
PMID: 29648728
A single-dose study was performed to observe the bioequivalence of the newly formulated carbamazepine-succinic cocrystal (CBZ-SUC) immediate release tablet (F(1)) with marketed immediate release formulation Epitoll 200 mg tablet (F(0))....
9.
Tulain U, Ahmad M, Rashid A, Iqbal F
Acta Pol Pharm
. 2018 Apr;
73(4):1009-1022.
PMID: 29648727
Present work concerned with development and evaluation of an innovative drug carrier, as smart drug delivery system for highly acid labile drug. Free radical polymerization technique was employed to develop...
10.
Riaz H, Goodman B, Bashir S, Hussain S, Mahmood S, Malik F, et al.
Acta Pol Pharm
. 2018 Apr;
73(4):999-1007.
PMID: 29648726
Alendronate sodium, a bisphosphonate drug, it is used to treat osteoporosis and other bone diseases. The present study was designed to conduct comparative bioavailability analysis of oral formulations of aledronate...